Ticker Details
Galecto, Inc. Common Stock
IPO Date:	October 29, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.73B
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.28 | 5.12%
Avg Daily Range (30 D):	$0.07 | 0.24%
Avg Daily Range (90 D):	$0.90 | 2.98%

Institutional Daily Volume
Avg Daily Volume:	.19M
Avg Daily Volume (30 D):	M
Avg Daily Volume (90 D):	.03M

Trade Size
Avg Trade Size (Sh.):	48
Avg Trade Size (Sh.) (30 D):	38
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	65
Avg Institutional Trade:	$2.1M
Avg Institutional Trade (30 D):	$2.33M
Avg Institutional Trade (90 D):	$2.19M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$2.78M
Avg Closing Trade (30 D):	$.56M
Avg Closing Trade (90 D):	$.56M
Avg Closing Volume:	87.3K

News

Feb 12, 2026 @ 9:01 PM Galecto Announces Closing of Public Offering and F... Source: Globe Newswire

Feb 11, 2026 @ 3:42 AM Galecto Announces Pricing of $275 Million Underwri... Source: Na

Dec 16, 2025 @ 10:00 PM Galecto, Inc. Announces Inducement Grant Under Nas... Source: Galecto, Inc.

Nov 10, 2025 @ 4:47 PM Galecto Stock Soars: Strengthens Blood Cancer Pipe... Source: Vandana Singh

Nov 10, 2025 @ 12:00 PM Galecto Announces Acquisition of Damora Therapeuti... Source: Galecto, Inc.

Financials
	TTM	FY 2025	Q3 2025
Basic EPS	$10.86	$3.98	$-2.36
Diluted EPS	$10.86	$3.98	$-2.36
Revenue	$1M	$1.17M	$.04M
Gross Profit
Net Income / Loss	$-200.74M	$-209.84M	$-3.1M
Operating Income / Loss	$-201.7M	$-210.87M	$-3.16M
Cost of Revenue
Net Cash Flow	$250.02M	$243.45M	$-2.61M
PE Ratio